$MRK Company News EU approves Merck's Erbitux for cancer

New Post Public Reply Private Reply Replies (0) Message Board

Dec 23, 2013 at 12:45 PM

$MRK Company News

EU approves Merck's Erbitux for cancer treatment 4:52 a.m. Today - MarketWatch.com
Biotechs continue to pay off 10:27 a.m. Dec. 20, 2013 - The Trading Deck
Safe and steady ETFs for the new year 12:03 p.m. Dec. 9, 2013 - Jim Lowell
Merck, McDonald's are top decliners in Dow index 4:05 p.m. Dec. 4, 2013 - Polya Lesova
Cuts, stock buyback, acquisition combine to boost Forest shares 11:09 a.m. Dec. 2, 2013 - blogs.marketwatch.com
Merck, J.P. Morgan lead Dow decliners 9:35 a.m. Nov. 13, 2013 - Laura Mandaro
Merck, Cisco lead gainers in Dow industrials 4:03 p.m. Nov. 12, 2013 - Polya Lesova
Bitcoin buying for dummies 3:22 p.m. Nov. 12, 2013 - blogs.marketwatch.com
Planned layoffs up 13.5% in October: Challenger 7:30 a.m. Nov. 6, 2013 - Steve Goldstein
Newscast: S&P 500 notches year's 32nd record high 8:08 p.m. Oct. 28, 2013 - MarketWatch
J.C. Penney, Bristol-Myers top S&P 500 7:08 p.m. Oct. 28, 2013 - Saumya Vaishampayan
S&P up for 8th day in 9; Dow, Nasdaq flat 4:57 p.m. Oct. 28, 2013 - Victor Reklaitis
Newscast: Stocks mixed after lackluster day 4:26 p.m. Oct. 28, 2013 - MarketWatch
Newscast: Car reliability ranks get new members 2:28 p.m. Oct. 28, 2013 - MarketWatch
Merck shares stumble on earnings weakness, talk of divesting assets 10:58 a.m. Oct. 28, 2013 - blogs.marketwatch.com
Merck, down 2.2%, leads Dow average lower 9:34 a.m. Oct. 28, 2013 - Laura Mandaro
Stock futures continue to waver after data 9:30 a.m. Oct. 28, 2013 - Sara Sjolin
Apple is Monday’s stock to watch as results loom 8:21 a.m. Oct. 28, 2013 - Sue Chang
Merck profit down 35% as Singulair sales fall 7:25 a.m. Oct. 28, 2013 - MarketWatch.com
Merck third-quarter profit, revenue fall 7:17 a.m. Oct. 28, 2013 - Saumya Vaishampayan

Gilead Sciences And The Numbers Game 9:51 a.m. Today - Seeking Alpha
Top 10 Dow Dividend Stocks for December 6:00 a.m. Today - InvestorPlace.com
European Commission Approves Update of Erbitux Metastatic Colorectal Cancer Labeling to Patients With RAS Wild-Type Tumors 5:17 a.m. Today - CNW Group
Merck & Co Inc (MRK): Today's Featured Drugs Winner 5:00 p.m. Dec. 20, 2013 - TheStreet.com
AsiaInfo And Simcere Bow Out From New York 2:14 p.m. Dec. 20, 2013 - Seeking Alpha
5 Stocks Moving The Drugs Industry Upward 12:02 p.m. Dec. 20, 2013 - TheStreet.com
Inovio CEO Interview: PD1/PDL1 Inhibitors, Immunotherapy And Why Investors Should Be Excited About 2014 11:30 a.m. Dec. 20, 2013 - Seeking Alpha
Merck Launches Weight-Management-Interventions Business 10:06 a.m. Dec. 20, 2013 - WSJ.com
What To Buy: Merck & Co Inc's Buy Recommendation Reiterated 9:00 a.m. Dec. 20, 2013 - TheStreet.com
'Dogs of the Dow' Strategy Should Be Muzzled 6:42 p.m. Dec. 19, 2013 - Barrons.com
Bristol-Myers Doubles Down on Cancer Focus 3:14 p.m. Dec. 19, 2013 - Barrons.com
The Battle Against Alzheimer's: Can An Investment In The Industry Prove Lucrative? 2:27 p.m. Dec. 19, 2013 - Seeking Alpha
French authority alleges anti-competitive practices in opioid addiction market 2:21 p.m. Dec. 19, 2013 - Seeking Alpha
Merck-Glaxo Partner for Oncology Treatment - Analyst Blog 1:20 p.m. Dec. 19, 2013 - Zacks.com
Stock Market News for December 19, 2013 - Market News 10:06 a.m. Dec. 19, 2013 - Zacks.com
Jim Cramer's Top Stock Picks: MRK AMAT CIEN XLNX GIS 6:00 a.m. Dec. 19, 2013 - TheStreet.com
Anacor Pharmaceuticals Is Not for Everyone 6:00 a.m. Dec. 19, 2013 - TheStreet.com
Sanofi Pipeline Doesn't Support Price 6:00 a.m. Dec. 19, 2013 - TheStreet.com
11 Stocks With Buybacks That Top $166 BILLION 12:16 a.m. Dec. 19, 2013 - InvestorPlace.com
Top Five Guru-Held Health Care Stocks 4:42 p.m. Dec. 18, 2013 - GuruFocus.com

New Clinical Trials, Stock Price Movements, and Completed Acquisitions - Research Report on Merck, Lilly, Allergan, PerkinElmer, and Air Methods 8:00 a.m. Today - PR Newswire
Obesity Stock Plays Standing Out from the Crowd 10:04 a.m. Dec. 20, 2013 - ACCESSWIRE
Merck Announces Launch of a New Business Focused on Comprehensive, Evidence-Based Weight Management Interventions in the U.S. 9:00 a.m. Dec. 20, 2013 - BusinessWire
Critical Alerts For eBay, Merck, Michael Kors, Delta Air Lines, and Tiffany Released By InvestorsObserver 9:31 a.m. Dec. 19, 2013 - PR Newswire
Merck Enters Into License Agreement With the Spanish National Cancer Research Centre (CNIO) 10:00 a.m. Dec. 18, 2013 - PR Newswire
Merck Collaborates with GlaxoSmithKline to Evaluate Novel Combination Regimen for Advanced Renal Cell Carcinoma 7:30 a.m. Dec. 18, 2013 - BusinessWire
Heat Biologics, Inc. Appoints Dr. Anil K. Goyal as Vice President of Business Development 8:01 a.m. Dec. 17, 2013 - Marketwire
Advisory Committee Recommendations, Voting Outcomes, New Appointments, and Stock Price Movements - Research Report on Merck, Bristol-Myers Squibb, Boston Scientific, WellCare, and PAREXEL 8:00 a.m. Dec. 17, 2013 - PR Newswire
MSD Animal Health Receives Positive Opinion from European Medicines Agency for BRAVECTO(TM) (fluralaner) 4:00 a.m. Dec. 17, 2013 - BusinessWire
When Prescribing New Drugs for Crohn's Disease or Ulcerative Colitis, Surveyed EU5 Gastroenterologists Will Prioritize Remission Rates Over Cost and Reimbursement Hurdles 8:00 a.m. Dec. 16, 2013 - PR Newswire
Clinical Studies Updates, and Stock Price Movements - Research Report on Merck, Select Medical Holdings, Galena Biopharma, Dendreon, and Echo Therapeutics 8:00 a.m. Dec. 16, 2013 - PR Newswire
Merck Statement on FDA Advisory Committee for GRASTEK(R) (Timothy Grass Pollen Allergen Extract), Merck's Investigational Sublingual Allergy Immunotherapy Tablet 7:17 p.m. Dec. 12, 2013 - BusinessWire
FDA Advisory Committee meeting unanimously recommends approval of GRASTEK (GRAZAX(R)) 4:13 p.m. Dec. 12, 2013 - GlobeNewswire
Heska Announces Extension of Tri-Heart(TM) Plus Heartworm Preventive Agreement with Merck Animal Health 9:00 a.m. Dec. 12, 2013 - PR Newswire
Reports, Positive Results, Updated Clinical Safety and Efficacy Data by Healthcare Companies - Research Report on Johnson & Johnson, Merck, BioMarin, Array BioPharma, and Brookdale Senior Living 8:00 a.m. Dec. 12, 2013 - PR Newswire
OncoSec Medical Announces Hire of Chief Medical Officer 6:05 a.m. Dec. 12, 2013 - BusinessWire
TechConnect World and National Innovation Summit Announce Lead Corporate Partners for 2014 10:00 a.m. Dec. 11, 2013 - PR Newswire
Pharma Industry Morning Assessment: Pfizer, Merck & Co., AbbVie, and Zogenix 12:19 p.m. Dec. 10, 2013 - PR Newswire
ALK announces posting of briefing documents for FDA Advisory Committee meeting on the grass sublingual AIT tablet 8:22 a.m. Dec. 10, 2013 - GlobeNewswire
Merck Advances Development Program for Investigational Alzheimer's Disease Therapy, MK-8931 7:00 a.m. Dec. 10, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson Unveils Promising PsA Treatment Data

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Quantum Space Joins $185M NASA Lunar Transport Deal

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Adding Fireplaces: Home Comfort or Construction Headache?

Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...

J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Aurora Innovation Faces Legal Heat Amid Delays

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Paris Baguette Pioneers Drive-Thru in Oklahoma

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

TCL's Display Future: AI Meets Screens at DTC 2026

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Evaluating GLP-1 Telehealth? Key Questions to Consider

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Boston STEM Expo Sparks Young Minds in Engineering

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Intelligent Communication Forum Eyes Global Ecosystem Shift

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...